Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease
eLife · 2024
DOI: 10.7554/elife.98649 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Yuki Date und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Graduate School of Science and Engineering, Chiba University, Inage-ku, Chiba, Japan. Hauptthemen laut MEDLINE: Lysosomes, Parkinson Disease, Autophagy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science London.
Abstract (Originalsprache)
The autophagy-lysosome pathway plays an indispensable role in the protein quality control by degrading abnormal organelles and proteins including α-synuclein (αSyn) associated with the pathogenesis of Parkinson’s disease (PD). However, the activation of this pathway is mainly by targeting lysosomal enzymic activity. Here, we focused on the autophagosome-lysosome fusion process around the microtubule-organizing center (MTOC) regulated by lysosomal positioning. Through high-throughput chemical screening, we identified 6 out of 1200 clinically approved drugs enabling the lysosomes to accumulate around the MTOC with autophagy flux enhancement. We further demonstrated that these compounds induce the lysosomal clustering through a JIP4-TRPML1-dependent mechanism. Among them, the lysosomal-clustering compound albendazole promoted the autophagy-dependent degradation of Triton-X-insoluble, proteasome inhibitor-induced aggregates. In a cellular PD model, albendazole boosted insoluble αSyn degradation. Our results revealed that lysosomal clustering can facilitate the breakdown of protein aggregates, suggesting that lysosome-clustering compounds may offer a promising therapeutic strategy against neurodegenerative diseases characterized by the presence of aggregate-prone proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Graduate School of Science and Engineering, Chiba University, Inage-ku, Chiba, Japan.
- Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
- Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Division for Development of Autophagy Modulating Drugs, Juntendo University Faculty of Medicine, Tokyo, Japan.
- Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan.
- Division of Gene Regulation, Cancer Center, Fujita Health University, Toyoake, Japan.
ORCID-Profile: Yuki Date, Yukiko Sasazawa, Nobutaka Hattori, Shinji Saiki
Förderung
- Japan Society for the Promotion of Science London
Zitieren
APA
Date, Y., Sasazawa, Y., Kitagawa, M., Gejima, K., Suzuki, A., Saya, H., Kida, Y., Imoto, M., Itakura, E., Hattori, N., & Saiki, S. (2024). Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease. eLife. https://doi.org/10.7554/elife.98649
Vancouver
Date Y, Sasazawa Y, Kitagawa M, Gejima K, Suzuki A, Saya H, et al. Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease. eLife. 2024. doi:10.7554/elife.98649
BibTeX
@article{Date2024,
author = {Date, Yuki and Sasazawa, Yukiko and Kitagawa, Mitsuhiro and Gejima, Kentaro and Suzuki, Ayami and Saya, Hideyuki and Kida, Yasuyuki and Imoto, Masaya and Itakura, Eisuke and Hattori, Nobutaka and Saiki, Shinji},
title = {Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.98649}
}
EUVIMED